Facts & Stats

• Acquired by Ilumina, February 2013
• Identifies fetal chromosomal abnormalities through the direct measurement of DNA resulting in a simpler, faster and earlier prenatal test that is easily integrated into existing clinical workflows.
• Current prenatal screening approaches rely on measurement of surrogate markers that yield highly variable results that are often inconclusive and confusing to both practitioners and patients.
• Highly experienced management team with key scientific and clinical advisory board members.

Facts & Stats

• Spina Bifida affects more than 3,000 births a year; it is the most common debilitating birth defect.
• Spina Bifida can be prevented if at-risk women are identified and begin folic acid therapy prior to conception.
• High dose folic acid is available only by prescription; it cannot be given to all women regardless of risk.
• VitaPath was founded in 2009.

Facts & Stats

• PreDx™ Diabetes Risk Score, a blood test that identifies 5-year risk of progression to type 2 diabetes.
• Sales of its PreDx® Diabetes Risk Score (DRS) test have exceeded 35,000 units sold since the product was commercially introduced in 2009.
• Tethys diagnostic tools allow for identification and focused intervention for those at most imminent disease risk.
• Primary care physicians can use the Tethys test to risk-stratify the 57 million people with prediabetes.  Worldwide hundreds of millions are at risk.
• Addressing preventable diseases like diabetes and other cardiometabolic diseases that have become pandemic.
• Company founded 2005 with a focus on using diagnostic tools to help prevent cardiometabolic disease.

Facts & Stats

• Entered into a global partnership with St. Jude Medical to co-market its cardiac rhythm monitors in May 2010.
• Received four FDA clearances within 14 months.
• Currently markets the Zio™ Patch (a prescription-only, single-use, continuously recording ECG monitor that can be worn for up to 7 days) and the Zio™ Event Card (a prescription-only, single-use, looping ECG monitor that can be worn for up to 30 days).
• Experienced Certified Cardiographic Technicians, based at the iRhythm National Clinical Center (iNCC), an Independent Diagnostic Testing Facility, provide monitoring services 24 hours a day, 7 days a week.
• iRhythm seeks to minimize environmental impact by designing devices 100% of which can be recycled.

Facts & Stats

• Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects over 1.5MM Americans.
• Approximately 3,500 rheumatologists treat patients with RA.
• Vectra DA provides unique insight into inflammatory disease activity at the molecular level.
• Crescendo was founded by a scientist driven by the profound effect autoimmune disorders have had on his family.

• Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects over 1.5MM Americans.
• Approximately 3,500 rheumatologists treat patients with RA.
• Vectra DA provides unique insight into inflammatory disease activity at the molecular level.
• Crescendo was founded by a scientist driven by the profound effect autoimmune disorders have had on his family.

Facts & Stats

• Maker of the world’s first and only clinically validated blood-based test for obstructive coronary artery disease, one of the single largest diagnostic markets in medicine.
• CardioDx was recently honored as one of FierceMedicalDevices' Fierce 15 most promising private companies.
• Named the 2012 Gold Edison Award winner for science and medical.
• In 2010, the company was honored as a winner of the Wall Street Journal’s prestigious Technology Innovation Awards.
• Corus^® CAD was named one of Time Magazine’s Top Ten Medical Breakthroughs.
• The PREDICT trial and the company’s scientific work has been published in Annals of Internal Medicine, Circulation Cardiovascular Genetics and the Journal of the American College of Cardiology.